BioDr. Hampl joined Great Point Partners’ CEO Advisory Board in 2011. He is the Co-Chairman of the Board of Directors of the GPP II portfolio company, Softbox and was previously the Co-Chairman of the Board of Directors of GPP I portfolio company, Cytovance Biologics. Dr. Hampl is President of BKH Pharma-Services and currently on the Board of Chenwerth, a leading Active Pharmaceutical Ingredient ("API") provider to th ....
Education